Nov 19 (Reuters) - Peptidream Inc 4587.T
* Peptidream announces discovery collaboration agreement
with
bayer
* Entered into a multi-target discovery collaboration with
Germany-based Bayer AG
* Under terms , co would receive undisclosed upfront payment
and
research funding
* Under terms, co is eligible to receive preclinical,
clinical,
commercialization milestone payments totaling up to $1.11
billion
* Also eligible to receive royalties on sales of any
products that
arise from collaboration
Source text for Eikon: ID:nBw1G6qcma
Further company coverage: 4587.T
((Bangalore.newsroom@thomsonreuters.com;))